Menu Close

Why new treatments for Alzheimer’s cost tens of thousands of dollars a year

The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer’s disease. Kisunla is an IV infusion therapy given once a month to people in the early stages of Alzheimer’s, according to the Alzheimer’s Association. The treatment destroys amyloid plaques in the brain to slow the progression of the disease.